Pacira BioSciences, Inc. PCRX Total debt
Total debt at other companies
Other financials
Where this comes from
Calculated from Pacira BioSciences, Inc.’s reported figures.
Plus components not separately reported this period.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s total debt?
- Pacira BioSciences, Inc. (PCRX) reported total debt of $411.18M in Q1 2026.
- How has Pacira BioSciences, Inc.'s total debt changed year-over-year?
- Pacira BioSciences, Inc.'s total debt increased by 15.3% year-over-year, from $356.66M to $411.18M.
- What is the long-term trend for Pacira BioSciences, Inc.'s total debt?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s total debt has grown at a 12.9% compound annual growth rate (CAGR), from $228.1M to $418.2M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.